XML 31 R22.htm IDEA: XBRL DOCUMENT v3.23.2
EARNINGS (LOSS) PER SHARE (Tables)
6 Months Ended
Jun. 30, 2023
Earnings Per Share [Abstract]  
SCHEDULE OF CALCULATIONS OF BASIC AND DILUTED EPS

The following calculates basic and diluted EPS:

 

   Three Months   Three Months 
   Ended   Ended 
   June 30, 2023   June 30, 2022 
(Loss) income from continuing operations, numerator, basic and diluted computation  $(3,869,732)  $10,660,028 
           
Weighted average common shares, basic   2,716,512    1,069,157 
Effect of series B warrants   -    - 
Effect of stock awards   -    2,128 
Effect of preferred stock   -    147,939 
Weighted average common shares, dilutive   2,716,512    1,219,224 
(Loss) earnings per common share – basic  $(1.42)  $9.97 
(Loss) earnings per common share – diluted  $(1.42)   8.74 

 

 

   Six Months   Six Months 
   Ended   Ended 
   June 30, 2023   June 30, 2022 
(Loss) income from continuing operations  $ (997,776)  $20,047,189 
Deemed dividend   -    (6,930,335)
Net income continuing operations, numerator, basic computation   (997,776)   13,116,854 
Recognition and change in fair value of warrant liabilities   -    (26,625,915)
Net loss continuing operations, numerator, diluted computation  $(997,776)  $(13,509,061)
           
Weighted average common shares, basic   2,138,444    1,025,108 
Effect of series B warrants   -    43,128 
Weighted average common shares, dilutive   2,138,444    1,068,236 
Loss per common share – basic   (0.47)   12.80 
Loss per common share – diluted  $(0.47)  $(12.65)
SCHEDULE OF DILUTIVE NET LOSS PER COMMON SHARES

Additionally, the following are considered anti-dilutive securities excluded from weighted-average shares used to calculate diluted net loss per common share:

 

   June 30, 2023   June 30, 2022 
   For the Three Months Ended 
   June 30, 2023   June 30, 2022 
Shares subject to outstanding common stock options   10,928    10,928 
Shares subject to outstanding Series A warrants   113,000    113,000 
Shares subject to outstanding Series F warrants   2,105,264    - 
Shares subject to placement agent warrants   52,632    - 
Shares subject to unvested stock awards   3,471    - 
Shares subject to conversion of Series B preferred stock   -    - 
Shares subject to warrant liability   -    668,299 

 

   June 30, 2023   June 30, 2022 
   For the Six Months Ended 
   June 30, 2023   June 30, 2022 
Shares subject to outstanding common stock options   10,928    10,928 
Shares subject to outstanding Series A warrants   113,000    113,000 
Shares subject to outstanding Series F warrants   2,105,264    - 
Shares subject to placement agent warrants   52,632    - 
Shares subject to unvested stock awards   3,471    4,621 
Shares subject to conversion of Series B preferred stock   -    147,939 
Shares subject to warrant liability   -    -